Regulatory News
Tuesday, January 3, 2017
BRIEF-Kite Pharma submitted an investigational new drug application with FDA
* Kite pharma - submitted an investigational new drug (ind)
application with U.S. Food and drug administration to initiate a
phase 1 trial of kite-718
Source text for Eikon:
Further company...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment